Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) | Synapse
May 18, 2024Open Access
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Key Points
Key points are not available for this paper at this time.
Abstract
University of Oxford Nuffield Department of Population Health Pump Priming.